🔗 Share this article

An underground market for unapproved slimming drugs is being driven by social media fitness personalities and vendors on messaging platforms, according to recent findings.

Experimental Drug Gaining Popularity Via Social Media

Retatrutide, which is still in clinical trials, is being promoted by online personalities for its alleged fat-burning effects. Viewers are encouraged to message these profiles directly for source information, while also receiving promotional offers.

Thriving Commerce on Messaging Platforms

Separately, a flourishing market exists on messaging services, where groups with numerous of members share “before and after” images, injection guides and claims of next-day UK delivery. Vendors market the substance there before directing customers to WhatsApp for transactions.

Understanding The Experimental Drug

This medication is an investigational injection created by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could help individuals lose up to 25% of their total weight. Referred to as the “triple G”, the substance is being promoted digitally as the next Ozempic.

Medical Professionals Express Worries

However, doctors and chemists have cautions that the sale of what remains an unapproved drug in the UK is a cause for concern and could result in users injecting substances of uncertain source.

Several experts said the demand for the experimental drug could be linked to the increasing cost of licensed slimming treatments such as Mounjaro.

Regulatory Position and Enforcement

Marketing retatrutide on TikTok or Telegram is prohibited in the United Kingdom, as it is an unapproved drug that must not be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.

Several content creators try to sidestep the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but advertising and distribution can still violate medicines, marketing, and customer regulations, potentially leading to fines, legal action or imprisonment.

Platform Reaction and Content Elimination

According to TikTok, the service has taken down problematic material and banned associated keywords and search suggestions. The company stated it was committed to maintaining the platform secure and allocating resources in strengthening compliance measures.

Online Trading Activities

Research also found groups with up to 9,000 participants marketing retatrutide using the platform's built-in search feature, which operates like a public directory. Entering “retatrutide” instantly brings up groups with thousands of users, filled with photos of slimming results, glowing reviews and detailed instructions for mixing or administering at residence.

After moments of joining one community, a seller posted WhatsApp details, where most transactions occur. The seller sent an guidebook and promised delivery within 48 hours. When asked whether the product was genuine, one seller said: “You can’t be sure.” Another shared a image of a alleged testing documentation. Not one asked about weight, medical conditions or previous experience.

Product Details and Pricing

Within these communities, messages show dark colored parcels with postal service labels, claiming to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, mixed at residence with sterile water, or ready-to-use injectors typically priced at 160 pounds for 20 milligrams. When questioned how long a pen should be used, sellers give contradictory answers varying between a few weeks to “depends on your body”.

Platform Moderation and Safety Actions

A representative for the messaging service stated it actively moderated harmful content on its service including content that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Warnings

“Individuals are injecting materials they cannot confirm. Even if the research behind this drug is valid, these online products may not contain what they advertise,” stated Jason Murphy, the head of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor linked the surge in demand to recent price rises for authorized weight-loss medications such as Mounjaro. “With prices increasing, patients are turning to social media. But counterfeit injections are highly dangerous. You can’t be certain what’s inside or whether the conditions they were made in was clean,” she said.

Her staff has already encountered patients harmed by self-injection from unconfirmed sources. “We understand the frustration, but buying from messaging apps or communication platforms is gambling with your health,” said Wyllie. “These substances could be impure or improperly measured.”

Manufacturer Statement

A spokesperson from Eli Lilly said the substance was in phase 3 research studies and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Consequently at this point no one can market [it] for personal consumption,” they said, adding that any item “misleadingly claiming itself as a company experimental product not yet approved … may expose patients to possibly significant health risks”.